Document is current
Any future updates will be listed below
-
Authors
Watanabe, Naoki
Takaku, Tomoiku
Iriyama, Noriyoshi
Iwanaga, Eisaku
Kimura, Yuta
Ishikawa, Maho
Nakayama, Hitomi
Sato, Eriko
Tabayashi, Takayuki
Mitsumori, Toru
Nakazato, Tomonori
Tokuhira, Michihide
Fujita, Hiroyuki
Ando, Miki
Miura, Katsuhiro
Kawaguchi, Tatsuya
- License Information
-
More Information
Article History
Received: 13 February 2025
Accepted: 23 June 2025
First Online: 19 July 2025
Declarations
:
: Approval of the research protocol by an Institutional Reviewer Board: This study was approved by the Ethics Committee of Juntendo University School of Medicine (H20-0088).
: TTak received speaker honoraria from Novartis Pharma K.K. and research funds from Bristol-Myers Squibb and Otsuka Pharmaceutical. NI received speaker honoraria from Bristol-Myers Squibb, Novartis Pharma K.K, Otsuka Pharmaceutical, and Pfizer Inc. EI received speaker honoraria from Bristol-Myers Squibb, Novartis Pharma K.K. and Otsuka Pharmaceutical. TTab received speaker honorarium from Jansen Pharmaceutical and scholarship funds from Chugai Pharmaceutical. MT received speaker honoraria from Bristol-Myers Squibb, Chugai Pharmaceutical, Novartis Pharma K.K., and Sanofi K.K. KM received a speaker honorarium from Novartis Pharma K.K., Bristol-Myers Squibb and Otsuka Pharmaceutical. TK received a speaker honorarium from Alexion Pharmaceuticals.
